ERBB2 and obesity due to melanocortin 4 receptor deficiency: Interestingly, a similar effect of overweight/obesity on pCR was demonstrated in HR-/HER2+ (OR = 0.522, P = 0.025) and HR + /HER2+ (OR = 0.525, P = 0.049) breast cancer patients in our analysis.